Pharma Industry Insights & Resources

Webinar | An Overview of the Main Regulatory Issues Affecting the Pharmaceutical Industry

With the existence of a wide variety of regulatory approaches in the different knowledge areas, it becomes a priority to encourage regulatory harmonization.

Case Study | How Intelligent Collaboration Transformed a Generic into a Best-in-Class New Drug

Read how collaboration and the drive to find a workable solution led to a successful drug development program.

A Beginner’s Guide to Technology Transfers

At the beginning of any commercial relationship with a CDMO, there is a technology transfer. Over the product lifecycle this may occur with other external partners and a product’s continued success can depend upon it.

Q&A with Pfizer CentreOne's CEO Andrew Moore - Pharmaceutical Technology

The new GM of Pfizer CentreOne Andrew Moore sat down with Pharmaceutical Technology to discuss his career, vision for the business and what excites him most about his new role.

The Importance of End-To-End Thinking During Drug Product Development - Outsourced Pharma

Throughout a drug product development program it is important to build robustness and flexibility into the manufacturing process. In this article, Dr.

Pfizer CentreOne's Regulatory Affairs team named a finalist of CPhI Excellence in Pharma Awards

Pfizer CentreOne's Regulatory Affairs team led by Chris Rojewski has been named as a finalist for the CPhI Excellence in Pharma Awards, Regulatory Procedures and Compliance category.

General Capabilities

Welcome to Pfizer CentreOne. We’re a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Working with our customers, we combine our technical and commercial knowledge with open dialogue to solve challenges – we call this intelligent collaboration.

Making the Medicine Go Down: Specialized Oral Solids Delivery Technologies

Most oral solids formulations are designed to release the drug immediately after swallowing for rapid absorption into the bloodstream.

Pfizer CentreOne's Partnership Promise

Strong commercial partnerships are based on trust and lasting relationships. For this reason, organizational changes can be unsettling. What will the new leader bring? What impact will the change have on my partnership? These are valid questions that should be addressed.

Pfizer CentreOne appoints new General Manager Andrew Moore

Pfizer CentreOne, a global pharmaceutical contract development and manufacturing organization (CDMO) embedded within Pfizer and a leading supplier of specialty APIs, today announced the appointment of Andrew Moore as general manager.

Oral Solid Dose Regulatory Hurdles and How to Approach Them

In your quest to meet the regulatory requirements for your oral solids project you may encounter significant hurdles. Anticipating these early on and thoroughly planning your approach can help.

Webinar | Key Trends in Contract Manufacturing

Growing demand for pharma and biotech outsourcing presents a tremendous opportunity for CDMOs, but the impact of COVID-19 adds to a growing list of considerations for finding the right commercial partners to deliver critical medicines. A recent CPhI webinar sponsored by Pfizer CentreOne she